Vertex Pharmaceuticals Incorporated shares owned by Assetmark
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Assetmark
from 13F filings
Historical chart of Assetmark investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Assetmark consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Assetmark
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $35M | 90k | 391.64 |
| 2025-06-30 | $41M | 92k | 445.20 |
| 2025-03-31 | $41M | 85k | 484.82 |
| 2024-12-31 | $32M | 80k | 402.70 |
| 2024-09-30 | $95M | 204k | 465.08 |
| 2024-06-30 | $178M | 380k | 468.72 |
| 2024-03-31 | $160M | 383k | 418.01 |
| 2023-12-31 | $158M | 387k | 406.89 |
| 2023-09-30 | $175M | 504k | 347.74 |
| 2023-06-30 | $180M | 511k | 351.91 |
| 2023-03-31 | $170M | 539k | 315.07 |
| 2022-12-31 | $116M | 402k | 288.78 |
| 2022-09-30 | $112M | 388k | 289.54 |
| 2022-06-30 | $2.1M | 7.6k | 281.83 |
| 2022-03-31 | $1.3M | 4.9k | 260.91 |
| 2021-12-31 | $400k | 1.8k | 219.66 |
| 2021-09-30 | $20k | 109 | 183.49 |
| 2021-06-30 | $30k | 148 | 202.70 |
| 2021-03-31 | $36k | 167 | 215.57 |
| 2020-12-31 | $31k | 133 | 233.08 |
| 2020-09-30 | $42k | 155 | 270.97 |
| 2020-06-30 | $90k | 309 | 291.26 |
| 2020-03-31 | $16k | 68 | 235.29 |
| 2019-12-31 | $16k | 73 | 219.18 |
| 2018-09-30 | $567k | 2.9k | 192.86 |
| 2018-06-30 | $515k | 3.0k | 170.08 |
| 2018-03-31 | $512k | 3.1k | 163.01 |
| 2017-12-31 | $2.6M | 17k | 149.87 |
| 2017-09-30 | $7.0k | 48 | 145.83 |
| 2017-06-30 | $1.0k | 11 | 90.91 |
| 2016-12-31 | $5.0k | 73 | 68.49 |
| 2016-09-30 | $10k | 113 | 88.50 |
| 2016-06-30 | $0 | 1 | 0.00 |
| 2016-03-31 | $0 | 1 | 0.00 |
| 2015-12-31 | $6.0k | 44 | 136.36 |
| 2015-09-30 | $999 | 12 | 83.33 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated